The global Gene Expression Screening market size is predicted to grow from US$ 117780 million in 2025 to US$ 212460 million in 2031; it is expected to grow at a CAGR of 10.3% from 2025 to 2031.
Gene Expression Screening is a form of personalized medicine - a way to learn more about your cancer and tailor your treatment. These tests are done on breast cancer cells after surgery or biopsy to look at the patterns of a number of different genes. This process or test is sometimes called gene expression profiling.
United States market for Gene Expression Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Gene Expression Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Gene Expression Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Gene Expression Screening players cover Abbott Laboratories, AutoGenomics, Biocartis, Bio-Rad Laboratories, Cepheid, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Gene Expression Screening Industry Forecast” looks at past sales and reviews total world Gene Expression Screening sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Expression Screening sales for 2025 through 2031. With Gene Expression Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Expression Screening industry.
This Insight Report provides a comprehensive analysis of the global Gene Expression Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Expression Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Expression Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Expression Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Expression Screening.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Expression Screening market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Chromosome
DNA
Biochemical
Segmentation by Application:
Single Gene Disorder
Gender Identification
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
AutoGenomics
Biocartis
Bio-Rad Laboratories
Cepheid
EKF Diagnostics
Elitech Group
IntegraGen
Interpace Diagnostics
Myriad Genetics
Perkin Elmer
Qiagen
Quest Diagnostics
Roche Diagnostics
WaferGen Biosystems
Key Questions Addressed in this Report
What is the 10-year outlook for the global Gene Expression Screening market?
What factors are driving Gene Expression Screening market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gene Expression Screening market opportunities vary by end market size?
How does Gene Expression Screening break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook